Skip to main content
ChoA Pharmaceutical Co., LTD. logo

ChoA Pharmaceutical Co., LTD. — Investor Relations & Filings

Ticker · 034940 ISIN · KR7034940007 KO Manufacturing
Open in API
Filings indexed 115 across all filing types
Latest filing 2021-12-16 Regulatory Filings
Country KR South Korea
Listing KO 034940

About ChoA Pharmaceutical Co., LTD.

https://www.choa.co.kr/en/

ChoA Pharmaceutical Co., LTD., established in 1988, is a company engaged in the development, manufacturing, and sale of pharmaceutical products and health supplements. The company's portfolio comprises approximately 200 products, including over-the-counter (OTC) drugs, generic medications, and functional health foods. It offers a diverse range of formulations such as tablets, capsules, granules, ampoules, and a notable selection of liquid and drinkable products. ChoA Pharmaceutical primarily supplies pharmacies and maintains a global business presence, exporting its products to more than 20 countries. The company focuses on developing high-quality medicines and health-related products to contribute to public well-being.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for the purpose of holding an Annual General Meeting (AGM). It does not contain the full meeting materials or proxy statements, but rather serves as a formal notice of the upcoming meeting's administrative requirements. Given its nature as a regulatory notification regarding corporate governance procedures, it fits best under the RNS category.
2021-12-16 Korean
분기보고서 (2021.09)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for Cho-A Pharm Co., Ltd. covering the period from January 1, 2021, to September 30, 2021. It contains detailed financial statements, management discussion, and operational data, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2021
2021-11-15 Korean
투자판단관련주요경영사항(작약복합추출물의 제2A상 임상시험계획 승인 양도·양수 계약 체결)
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from Cho-A Pharmaceutical regarding a 'Major Management Matter' (투자판단 관련 주요경영사항). It details the transfer of rights for a clinical trial (Phase 2A) of a peony complex extract to another company, Genoheal. This is a specific corporate announcement regarding business operations and asset transfers, which falls under the general regulatory filing category as it does not fit into specific categories like M&A (which usually refers to corporate mergers/acquisitions of entities) or other specialized reports.
2021-10-19 Korean
반기보고서 (2021.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-annual Report) for Cho-A Pharm Co., Ltd. covering the period from January 1, 2021, to June 30, 2021. It contains comprehensive financial statements, management discussion and analysis, and operational details, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2021
2021-08-17 Korean
[기재정정]사업보고서 (2020.12)
Annual Report Classification · 1% confidence The document is a 'Correction Report' (정정신고) for a previously filed 'Business Report' (사업보고서), which is the Korean equivalent of an Annual Report (10-K). The document contains detailed financial and operational updates, including corrections to dividend policies, research and development activities, subsidiary investments, and legal/regulatory sanctions. Since it is a formal amendment to an existing Annual Report containing substantive financial and operational data, it is classified as an Annual Report (10-K). FY 2020
2021-06-10 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for Cho-A Pharmaceutical Co., Ltd. for the period ending March 31, 2021. It contains detailed financial information, business descriptions, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2021
2021-05-17 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.